Argenx
ARGX
#571
Rank
ยฃ28.79 B
Marketcap
ยฃ481.47
Share price
1.54%
Change (1 day)
21.96%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : ยฃ0.42 Billion

According to Argenx 's latest financial reports the company's total liabilities are ยฃ0.42 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Argenx - Total liabilities on balance sheet (from 2021 to 2020)

Total liabilities by year

Year Total liabilities Change
2022-12-31ยฃ0.26 B13.17%
2021-12-31ยฃ0.23 B-57.14%
2020-12-31ยฃ0.54 B48.77%
2019-12-31ยฃ0.36 B789%
2018-12-31ยฃ41.3 M49.28%
2017-12-31ยฃ27.66 M-27.21%
2016-12-31ยฃ38.01 M442.62%
2015-12-31ยฃ7 M-12.5%
2014-12-31ยฃ8 M109.34%
2013-12-31ยฃ3.82 M-25.56%
2012-12-31ยฃ5.13 M52.11%
2011-12-31ยฃ3.37 M93.21%
2010-12-31ยฃ1.74 M